Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A

Cited by (902)

Items 101–200 of 902

1. Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation
   Na Li, Bianca J.J.M. Brundel · 2020 · Circulation Research
2. Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines
   Eugene Guorong Yang, Nurulhuda Binte Mustafa, Eng Chong Tan, Anders Poulsen, Pondy Murugappan Ramanujulu, Wee Joo Chng, Jeffrey J. Y. Yen, Brian William Dymock · 2016 · Journal of Medicinal Chemistry
3. Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated
   Magalie N. E. Géraldy, Michael Morgen, Peter A. Sehr, Raphael R. Steimbach, Davide Moi, Johannes Ridinger, Ina Oehme, Olaf Witt, Mona Malz, Mauro S. Nogueira et al. · 2019 · Journal of Medicinal Chemistry
4. Discovery of histone deacetylase 8 selective inhibitors
   Weiping Tang, Tuoping Luo, Edward F. Greenberg, James E. Bradner, Stuart L. Schreiber · 2011 · Bioorganic & Medicinal Chemistry Letters
5. Towards Selective Inhibition of Histone Deacetylase Isoforms: What Has Been Achieved, Where We Are and What Will Be Next
   Florian Thaler, Ciro Mercurio · 2013 · ChemMedChem
6. A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
   Sida Shen, Alan P. Kozikowski · 2019 · Expert Opinion on Therapeutic Patents
7. How Does Chirality Determine the Selective Inhibition of Histone Deacetylase 6? A Lesson from Trichostatin A Enantiomers Based on Molecular Dynamics
   Yang Zhang, Jun Biao Ying, Jia Jun Hong, Fengcheng Li, Ting Ting Fu, Feng Yuan Yang, Guo Xun Zheng, Xiao Yao, Yan Lou, Yunqing Qiu et al. · 2019 · ACS Chemical Neuroscience
8. Discovery of the First Histone Deacetylase 6/8 Dual Inhibitors
   David E. Olson, Florence F. Wagner, Taner Kaya, Jennifer P. Gale, Nadia Aidoud, Emeline L. Davoine, Fanny Lazzaro, Michel Weïwer, Yanling Zhang, Edward B. Holson · 2013 · Journal of Medicinal Chemistry
9. Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models
   Yves Depetter, Silke Geurs, Rob De Vreese, Sophie Goethals, Elien Vandoorn, Alien Laevens, Jonas Steenbrugge, Evelyne Meyer, Pascal De Tullio, Marc Bracke et al. · 2019 · International Journal of Cancer
10. The Pictet-Spengler Reaction Updates Its Habits
    Andrea Calcaterra, Laura Mangiardi, Giuliano Delle Monache, Deborah Quaglio, Silvia Balducci, Simone Berardozzi, Antonia Iazzetti, Roberta Franzini, Bruno Botta, Francesca Ghirga · 2020 · Molecules
11. Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy
    Zigao Yuan, Shaopeng Chen, Qinsheng Sun, Ning Wang, Dan Li, Shuangshuang Miao, Chunmei Gao, Yu Chen, Chunyan Tan, Yuyang Jiang · 2017 · Bioorganic & Medicinal Chemistry
12. Actin filaments play a primary role for structural integrity and viscoelastic response in cells
    Alperen N. Ketene, Paul Christopher Roberts, Amanda A. Shea, Eva M. Schmelz, Masoud Agah · 2012 · Integrative Biology
13. (N-Hydroxycarbonylbenylamino)quinolines as Selective Histone Deacetylase 6 Inhibitors Suppress Growth of Multiple Myeloma in Vitro and in Vivo
    Hsueh‐Yun Lee, Kunal Nepali, Fang-I Huang, C.S. Chang, Mei-Jung Lai, Yu-Hsuan Li, Hsiang-Ling Huang, Chia‐Ron Yang, Jing‐Ping Liou · 2018 · Journal of Medicinal Chemistry
14. HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila
    Ying Xiong, Kai Zhao, Jiaxi Wu, Zhiheng Xu, Shan Jin, Yongqing Zhang · 2013 · Proceedings of the National Academy of Sciences
15. Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer’s Disease
    Obdulia Rabal, Juan Antonio Sánchez-Arias, Mar Cuadrado‐Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García, Ana Ugarte, Ander Estella‐Hermoso de Mendoza, Elena Sáez, María Espelosin et al. · 2016 · Journal of Medicinal Chemistry
16. Natural chalcones as dual inhibitors of HDACs and NF-κB
    Barbora Orlikova, Michaël Schnekenburger, Mire Zloh, František Golais, Marc F. Diederich, Deniz Taşdemir · 2012 · Oncology Reports
17. Structural and in Vivo Characterization of Tubastatin A, a Widely Used Histone Deacetylase 6 Inhibitor
    Sida Shen, Michal Svoboda, Guangming Zhang, Maria A. Cavasin, L. Motlova, Timothy A. McKinsey, James H. Eubanks, Cyril Bařinka, Alan P. Kozikowski · 2020 · ACS Medicinal Chemistry Letters
18. β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer’s Disease Therapy
    Aurélien Beato, Anthonin Gori, Benjamin Boucherle, Marine Peuchmaur, Romain Haudecoeur · 2021 · Journal of Medicinal Chemistry
19. Current understanding of the molecular mechanisms of chemotherapy-induced peripheral neuropathy
    Xinyu Chen, Yumeng Gan, Ngan Pan Bennett Au, Chi Him Eddie Ma · 2024 · Frontiers in Molecular Neuroscience
20. HDAC6 Brain Mapping with [18F]Bavarostat Enabled by a Ru-Mediated Deoxyfluorination
    Martin G. Strebl, Arthur J. Campbell, Wen‐Ning Zhao, Frederick A. Schroeder, Misha M. Riley, Peter S. Chindavong, Thomas Morin, Stephen J. Haggarty, Florence F. Wagner, Tobias Ritter et al. · 2017 · ACS Central Science
21. The Acetylation of Lysine-376 of G3BP1 Regulates RNA Binding and Stress Granule Dynamics
    József Gál, Jing Chen, Duck-Young Na, Laura Tichacek, Kelly R. Barnett, Haining Zhu · 2019 · Molecular and Cellular Biology
22. Epigenetic drug discovery for Alzheimer’s disease
    Ramón Cacabelos, Clara Torrellas · 2014 · Expert Opinion on Drug Discovery
23. Iodine-Mediated Cascade Cyclization of Enediynes to Iodinated Benzo[a]carbazoles
    Chin‐Chau Chen, Shyh‐Chyun Yang, Ming‐Jung Wu · 2011 · The Journal of Organic Chemistry
24. Histone Deacetylase Inhibitors (HDACis) That Release the Positive Transcription Elongation Factor b (P-TEFb) from Its Inhibitory Complex Also Activate HIV Transcription
    Koen Bartholomeeusen, Koh Fujinaga, Yanhui Xiang, Boris Matija Peterlin · 2013 · Journal of Biological Chemistry
25. Discovery of a New Isoxazole-3-hydroxamate-Based Histone Deacetylase 6 Inhibitor SS-208 with Antitumor Activity in Syngeneic Melanoma Mouse Models
    Sida Shen, Melissa M. Hadley, Kseniya Ustinova, Jiřı́ Pavlı́ček, Tessa J. Knox, Satish Kumar Reddy Noonepalle, Maurício T. Tavares, Chad Zimprich, Guiping Zhang, Matthew B. Robers et al. · 2019 · Journal of Medicinal Chemistry
26. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson’s disease
    Brígida R. Pinho, Sara Reis, Pedro Guedes-Dias, Ana Leitão-Rocha, Clara Quintas, Patrı́cia Valentão, Paula B. Andrade, Miguel Machado Santos, Jorge M. A. Oliveira · 2015 · Pharmacological Research
27. The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease
    Sri Nagarjun Batchu, Angela S. Brijmohan, Andrew Advani · 2016 · Clinical Science
28. Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease
    Veronick Benoy, Pieter Vanden Berghe, Matthew B. Jarpe, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch · 2016 · Neurotherapeutics
29. High-selective HDAC6 inhibitor promotes HDAC6 degradation following autophagy modulation and enhanced antitumor immunity in glioblastoma
    Jia-Rong Liu, Chao‐Wu Yu, Pei-Yun Hung, Ling‐Wei Hsin, Ji‐Wang Chern · 2019 · Biochemical Pharmacology
30. The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
    Maria Cosenza, Samantha Pozzi · 2018 · International Journal of Molecular Sciences
31. Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot–Marie–Tooth Disease
    Sida Shen, Veronick Benoy, Joel A. Bergman, Jay H. Kalin, Mariana C. F. C. B. Damião, Giulio Vistoli, Wanda Haeck, Ludo Van Den Bosch, Alan P. Kozikowski · 2015 · ACS Chemical Neuroscience
32. Marbostat-100 Defines a New Class of Potent and Selective Antiinflammatory and Antirheumatic Histone Deacetylase 6 Inhibitors
    Andreas Sellmer, Hubert Stangl, Mandy Beyer, Elisabeth Grünstein, Michel Leonhardt, Herwig Pongratz, Emerich Eichhorn, Sigurd Elz, Birgit Striegl, Zsuzsa Jenei‐Lanzl et al. · 2018 · Journal of Medicinal Chemistry
33. The inflammatory cytokine IL-6 induces FRA1 deacetylation promoting colorectal cancer stem-like properties
    Tingyang Wang, Ping Song, Tingting Zhong, Xianjun Wang, Xueping Xiang, Qian Liu, Haiyi Chen, Tian Xia, Hong Liu, Yumiao Niu et al. · 2019 · Oncogene
34. HDAC inhibitor therapy in autoimmunity and transplantation
    Wayne W. Hancock, Tatiana Akimova, Ulf Henning Beier, Yujie Liu, Liqing Wang · 2012 · Annals of the Rheumatic Diseases
35. Inhibition of Histone Deacetylase 6 (HDAC6) as a therapeutic strategy for Alzheimer's disease: A review (2010–2020)
    Li, Yunheng, Sang, Shenghu, Ren, Weijie, Pei, Yuqiong, Bian, Yaoyao, Chen, Yao, Sun, Haopeng · 2021 · European Journal of Medicinal Chemistry
36. Recent contributions of quinolines to antimalarial and anticancer drug discovery research
    Tim Van de Walle, Lore Cools, Sven Mangelinckx, Matthias D’hooghe · 2021 · European Journal of Medicinal Chemistry
37. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes
    Monika Noack, Janina Leyk, Christiane Richter‐Landsberg · 2014 · Glia
38. Chromatin-modifying agents in anti-cancer therapy
    Carole Seidel, Cristina Florean, Michaël Schnekenburger, Mario A. Dicato, Marc F. Diederich · 2012 · Biochimie
39. 5-Aroylindoles Act as Selective Histone Deacetylase 6 Inhibitors Ameliorating Alzheimer’s Disease Phenotypes
    Hsueh‐Yun Lee, Sheng-Jun Fan, Fang-I Huang, Hsin-Yi Chao, Kai‐Cheng Hsu, Tony Eight Lin, Teng‐Kuang Yeh, Mei-Jung Lai, Yu-Hsuan Li, Hsiang-Ling Huang et al. · 2018 · Journal of Medicinal Chemistry
40. TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types
    Nanne Aben, Daniël J. Vis, Magali Michaut, Lodewyk F.A. Wessels · 2016 · Bioinformatics
41. Emerging approaches for histone deacetylase inhibitor drug discovery
    Clemens Zwergel, Sérgio Valente, Claus Jacob, Antonello Mai · 2015 · Expert Opinion on Drug Discovery
42. A microenvironment-mediated c-Myc/miR-548m/HDAC6 amplification loop in non-Hodgkin B cell lymphomas
    Tint Lwin, Xiaohong Zhao, Fengdong Cheng, Xinwei Zhang, Andy Huang, Bijal Dinesh Shah, Yizhuo Zhang, Lynn C. Moscinski, Yong Sung Choi, Alan P. Kozikowski et al. · 2013 · Journal of Clinical Investigation
43. Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity
    Işın Çakır, Colleen K. Hadley, Pauline Lining Pan, Rushita Adhikari Bagchi, Masoud Ghamari‐Langroudi, Danielle T. Porter, Qiuyu Wang, Michael J. Litt, Somnath Jana, Susan E. Hagen et al. · 2022 · Nature Metabolism
44. Structural basis for the design and synthesis of selective HDAC inhibitors
    Simone Di Micco, Maria Giovanna Chini, Stefania Terracciano, Ines Bruno, Raffaele Riccio, Giuseppe Bifulco · 2013 · Bioorganic & Medicinal Chemistry
45. 3-Hydroxypyridin-2-thione as Novel Zinc Binding Group for Selective Histone Deacetylase Inhibition
    Vishal Patil, Quaovi H. Sodji, James R. Kornacki, Milan Mrksich, Adegboyega K. Oyelere · 2013 · Journal of Medicinal Chemistry
46. Iodine-Catalyzed Cascade Formal [3 + 3] Cycloaddition Reaction of Indolyl Alcohol Derivatives with Enaminones: Constructions of Functionalized Spirodihydrocarbolines
    Wen‐Juan Hao, Shun‐Yi Wang, Shun‐Jun Ji · 2013 · ACS Catalysis
47. Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities
    Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Fernanda Savacini Sagrillo, María Laura Bolognesi, Carlos Alberto Manssour Fraga · 2020 · Medicinal Research Reviews
48. HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease
    Brijmohan, Angela S., Batchu, Sri N., Majumder, Syamantak, Alghamdi, Tamadher A., Thieme, Karina, McGaugh, Sarah, Liu, Youan, Advani, Suzanne L., Bowskill, Bridgit B., Kabir, M. Golam et al. · 2018 · Frontiers in Pharmacology
49. Indirubin Derivatives as Dual Inhibitors Targeting Cyclin-Dependent Kinase and Histone Deacetylase for Treating Cancer
    Zhuoxian Cao, Fen‐Fen Yang, Jie Wang, Zhicheng Gu, Shuxian Lin, Pan Wang, Jianxiong An, Ting Liu, Yan Li, Yongjun Li et al. · 2021 · Journal of Medicinal Chemistry
50. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
    Antonio Curcio, Roberta Rocca, Stefano Alcaro, Anna Artese · 2024 · Pharmaceuticals
51. Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7–HMGA2–Cyclin A2 Pathway
    Yixuan Li, Lirong Peng, Edward Seto · 2015 · Molecular and Cellular Biology
52. Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease
    Obdulia Rabal, Juan Antonio Sánchez-Arias, Mar Cuadrado‐Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García, Ana Ugarte, Ander Estella‐Hermoso de Mendoza, Elena Sáez, María Espelosin et al. · 2018 · European Journal of Medicinal Chemistry
53. Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma
    Hiroshi Nakashima, Johanna K. Kaufmann, Pin-Yi Wang, Tran Nguyen, Maria Carmela Speranza, Kazue Kasai, Kazuo Okemoto, Akihiro Otsuki, Ichiro Nakano, Soledad Fernández et al. · 2015 · Journal of Clinical Investigation
54. HSP90 inhibitor geldanamycin reverts IL-13– and IL-17–induced airway goblet cell metaplasia
    Alejandro A. Pezzulo, R.A. Tudas, Carley G. Stewart, Luis G. Vargas Buonfiglio, Brian D. Lindsay, Peter J. Taft, Nicholas D. Gansemer, Joseph Zabner · 2019 · Journal of Clinical Investigation
55. Primary cilia in stem cells and neural progenitors are regulated by neutral sphingomyelinase 2 and ceramide
    Qian He, Guanghu Wang, Sushama Wakade, Somsankar Dasgupta, Michael B. Dinkins, Ji Na Kong, Stefka D. Spassieva, Erhard Bieberich · 2014 · Molecular Biology of the Cell
56. A novel HDAC6 inhibitor Tubastatin A: Controls HDAC6-p97/VCP-mediated ubiquitination-autophagy turnover and reverses Temozolomide-induced ER stress-tolerance in GBM cells
    Zongyang Li, Ce Zhang, Yuan Zhang, Lei Chen, Bao-dong Chen, Qingzhong Li, Xiejun Zhang, Weiping Li · 2017 · Cancer Letters
57. Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma
    Xiaopeng Peng, Ling Li, Jingxuan Chen, Yichang Ren, Jin Liu, Ziwen Yu, Hao Cao, Jianjun Chen · 2022 · Journal of Medicinal Chemistry
58. Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer’s and Parkinson’s Diseases
    Óscar Teijido, Ramón Cacabelos · 2018 · International Journal of Molecular Sciences
59. ATAT1-enriched vesicles promote microtubule acetylation via axonal transport
    Aviel Even, Giovanni Morelli, Loïc Broix, Chiara Scaramuzzino, Silvia Turchetto, Ivan Enghian Gladwyn-Ng, Romain Le Bail, Michal Shilian, Stephen D. Freeman, Maria M. Magiera et al. · 2019 · Science Advances
60. A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth
    Kaliszczak, M, Trousil, S, Åberg, O, Perumal, M, Nguyen, Q-D, Aboagye, E O · 2013 · British Journal of Cancer
61. Actin-microtubule cytoskeletal interplay mediated by MRTF-A/SRF signaling promotes dilated cardiomyopathy caused by LMNA mutations
    Caroline Le Dour, Maria Chatzifrangkeskou, Coline Macquart, Maria M. Magiera, Cécile Peccate, Charlène Jouve, Laura Virtanen, Tiina M. Heliö, Katriina Aalto‐Setälä, Silvia Crasto et al. · 2022 · Nature Communications
62. Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth
    Lawrence Van Helleputte, Mandy S. J. Kater, Dana Paulina Cook, Caroline Eykens, Elisabeth Rossaert, Wanda Haeck, Tom Jaspers, Natasja Geens, Pieter Vanden Berghe, Conny A. Gysemans et al. · 2017 · Neurobiology of Disease
63. Uncovering Robust Delactoylase and Depyruvoylase Activities of HDAC Isoforms
    Matthes Zessin, Marat Meleshin, Lucas Praetorius, Wolfgang Sippl, Cyril Bařinka, Mike Schutkowski · 2022 · ACS Chemical Biology
64. Hdac6 regulates Tip60-p400 function in stem cells
    Poshen B. Chen, Jui‐Hung Hung, Taylor L. Hickman, Andrew H. Coles, James F. Carey, Zhiping Weng, Feixia Chu C, Thomas G. Fazzio · 2013 · eLife
65. Entropy as a Driver of Selectivity for Inhibitor Binding to Histone Deacetylase 6
    Porter, Nicholas J., Wagner, Florence F., Christianson, David W. · 2018 · Biochemistry
66. Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model
    Yongqing Li, Ting Zhao, Baoling Liu, Ihab F. Halaweish, Ralph Mazitschek, Xiuzhen Duan, Hasan Badre Alam · 2015 · The Journal of Trauma: Injury, Infection, and Critical Care
67. Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury
    Jinhua Tang, Yingfeng Shi, Na Liu, Liuqing Xu, Xiujuan Zang, LI Pei-bin, Juanlian Zhang, Xiaoqing Zheng, Andong Qiu, Shougang Zhuang · 2018 · Clinical Science
68. ASK1-Mediated Phosphorylation Blocks HDAC6 Ubiquitination and Degradation to Drive the Disassembly of Photoreceptor Connecting Cilia
    Jie Ran, Min Liu, Jie Feng, Haixia Li, Huixian Ma, Ting Song, Yu Wen Cao, Peng Zhou, Yuhan Wu, Yunfan Yang et al. · 2020 · Developmental Cell
69. A selective histone deacetylase-6 inhibitor improves BDNF trafficking in hippocampal neurons from Mecp2 knockout mice: implications for Rett syndrome
    Xin Xu, Alan P. Kozikowski, Lucas D. Pozzo‐Miller · 2014 · Frontiers in Cellular Neuroscience
70. Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
    Guozhi Tang, Jason C. Wong, Weixing Zhang, Zhanguo Wang, Nan Zhang, Zhenghong Peng, Zhenshan Zhang, Yiping Rong, Shijie Li, Meifang Zhang et al. · 2014 · Journal of Medicinal Chemistry
71. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness
    Janina Leyk, Conor Daly, Ulrike Janssen‐Bienhold, Breandán N. Kennedy, Christiane Richter‐Landsberg · 2017 · Cell Death and Disease
72. CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus
    Eun Wha Choi, Ji Woo Song, Nina Ha, Young Il Choi, Sungjoo Kim · 2018 · Scientific Reports
73. Rational Design of Suprastat: A Novel Selective Histone Deacetylase 6 Inhibitor with the Ability to Potentiate Immunotherapy in Melanoma Models
    Satish Kumar Reddy Noonepalle, Sida Shen, J. Ptáček, Maurício T. Tavares, Guiping Zhang, Jan Stránský, Jiřı́ Pavlı́ček, Gláucio Monteiro Ferreira, Melissa M. Hadley, Guido D. Pelaez et al. · 2020 · Journal of Medicinal Chemistry
74. A review of synthetic bioactive tetrahydro-β-carbolines: A medicinal chemistry perspective
    Jiayun Wang, Feihu Gong, Ting Liang, Zhao Xie, Ying-Xiang Yang, Chenyu Cao, Jin‐Ming Gao, Tao Lu, Xin Chen · 2021 · European Journal of Medicinal Chemistry
75. Lysine deacetylases and mitochondrial dynamics in neurodegeneration
    Pedro Guedes-Dias, Jorge M. A. Oliveira · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
76. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema
    Jinyan Yu, Zhongsen Ma, Sreerama Shetty, Mengshi Ma, Jian Fu · 2016 · American Journal of Physiology-Lung Cellular and Molecular Physiology
77. Upregulation of MDH1 acetylation by HDAC6 inhibition protects against oxidative stress-derived neuronal apoptosis following intracerebral hemorrhage
    Miao Wang, Chao Zhou, Lu Yu, Delian Kong, Wei-jing Ma, Bingchen Lv, Yan Wang, Wei-Feng Wu, Mingyue Zhou, Guiyun Cui · 2022 · Cellular and Molecular Life Sciences
78. The PI3K/AKT pathway promotes gefitinib resistance in mutant KRAS lung adenocarcinoma by a deacetylase‐dependent mechanism
    Victor Jeannot, Benoît Busser, Elisabeth M. Brambilla, Marie Wislez, Blaise Robin, Jacques L. Cadranel, Jean‐Luc Coll, Amandine Hurbin · 2013 · International Journal of Cancer
79. Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity
    Laetitia Francelle, Tiago F. Outeiro, Gudrun Rappold · 2020 · Scientific Reports
80. Astrocyte-mediated inflammatory responses in traumatic brain injury: mechanisms and potential interventions
    Haifeng Zhang, Xian Zhang, Yan Chai, Yuhua Wang, Jianning Zhang, Xin Chen · 2025 · Frontiers in Immunology
81. Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators
    Peng Zhan, Yukihiro Itoh, Takayoshi Suzuki, Xinyong Liu · 2015 · Journal of Medicinal Chemistry
82. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation
    Zhexi Chi, Hye-Eun Byeon, Eunjeong Seo, Quynh-Anh T. Nguyen, Wonbeom Lee, Yunyong Jeong, Juyong Choi, Deepesh Pandey, Dan E. Berkowitz, Jae Hyung Kim et al. · 2019 · Pharmacological Research
83. Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease
    Angela De Simone, Valeria La Pietra, Nibal Betari, Nicola Petragnani, Mariarosaria Conte, Simona Daniele, Deborah Pietrobono, Claudia Martini, Sabrina Petralla, Raffaella Casadei et al. · 2019 · ACS Medicinal Chemistry Letters
84. Enhancement of Stress Resilience Through Histone Deacetylase 6–Mediated Regulation of Glucocorticoid Receptor Chaperone Dynamics
    Jeanine Jochems, Sarah L. Teegarden, Yong Chen, Janette Boulden, Collin Challis, Gabriel A. Ben-Dor, Sangwon F. Kim, Olivier Berton · 2014 · Biological Psychiatry
85. Loss of HDAC6 alters gut microbiota and worsens obesity
    Arnon D. Lieber, Ulf Henning Beier, Haiyan Xiao, Benjamin J. Wilkins, Jing Jiao, Xinmin S. Li, Rebecca C. Schugar, Christopher Strauch, Zeneng Wang, Jonathan Mark Brown et al. · 2018 · The FASEB Journal
86. Histone Modification of<i>Nedd4</i>Ubiquitin Ligase Controls the Loss of AMPA Receptors and Cognitive Impairment Induced by Repeated Stress
    Wei, Jing, Xiong, Zhe, Lee, Janine B., Cheng, Jia, Duffney, Lara J., Matas, Emmanuel, Yan, Zhen · 2016 · The Journal of Neuroscience
87. HDAC6 as a target for antileukemic drugs in acute myeloid leukemia
    Björn W. Hackanson, David Leander Rimmele, Marco Benkißer-Petersen, Mahmoud Abdelkarim, Manfred Fliegauf, Manfred Jung, Michael Lübbert · 2012 · Leukemia Research
88. Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation
    Barbara Vergani, Giovanni Sandrone, Mattia Marchini, Chiara Ripamonti, Edoardo Cellupica, Elisabetta Galbiati, Gianluca Caprini, Gianfranco Pavich, Giulia Porro, Ilaria Rocchio et al. · 2019 · Journal of Medicinal Chemistry
89. Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer
    Sravani Pulya, Tarun Kumar Patel, Milan Paul, Nilanjan Adhikari, Suvankar Banerjee, Ganesh Routholla, Swati Biswas, Tarun Jha, Balaram Ghosh · 2022 · European Journal of Medicinal Chemistry
90. Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors
    Rob De Vreese, Matthias D’hooghe · 2017 · European Journal of Medicinal Chemistry
91. Recent developments on synthesis and biological activities of γ-carboline
    Jiangkun Dai, Wenjia Dan, Yunyun Zhang, Junru Wang · 2018 · European Journal of Medicinal Chemistry
92. HDAC6 regulates microtubule stability and clustering of AChRs at neuromuscular junctions
    Alexis Osseni, Aymeric Ravel‐Chapuis, Jean-Luc Thomas, Vincent Gache, Laurent Schaeffer, Bernard Jean Jasmin · 2020 · The Journal of Cell Biology
93. Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines
    Yudibeth Sixto‐López, José Antonio Gómez-Vidal, Nuria de Pedro, Martiniano Bello, Martha Cecilia Rosales‐Hernández, José Correa‐Basurto · 2020 · Scientific Reports
94. Identification of novel chemotherapeutic strategies for metastatic uveal melanoma
    Paolo Fagone, Rosario Caltabiano, Andrea Russo, Gabriella Lupo, Carmelina Daniela Anfuso, Maria Sofia Basile, Antonio Longo, Ferdinando Nicoletti, Rocco De Pasquale, Massimo Libra et al. · 2017 · Scientific Reports
95. Phenotypic screening with deep learning identifies HDAC6 inhibitors as cardioprotective in a BAG3 mouse model of dilated cardiomyopathy
    Jin Yang, Francis Grafton, Sara Ranjbarvaziri, Ana Budan, Farshad Farshidfar, Marie Cho, Emma Xu, Jaclyn J. Ho, Mahnaz Maddah, Kevin E. Loewke et al. · 2022 · Science Translational Medicine
96. HDAC6: Physiological function and its selective inhibitors for cancer treatment
    Penghui Yang · 2013 · Drug Discoveries & Therapeutics
97. Microtubule-Associated Histone Deacetylase 6 Supports the Calcium Store Sensor STIM1 in Mediating Malignant Cell Behaviors
    Ying‐Ting Chen, Yih‐Fung Chen, Wen‐Tai Chiu, Kuan-Yu Liu, Yu-Lin Liu, Jang‐Yang Chang, Hsien‐Chang Chang, Meng‐Ru Shen · 2013 · Cancer Research
98. Histone deacetylase 6 inhibition restores autophagic flux to promote functional recovery after spinal cord injury
    Zhilong Zheng, Yajiao Zhou, Luxia Ye, Qi Lu, Kairui Zhang, Jing Zhang, Lin Xie, Yanqing Wu, Ke Xu, Hongyu Zhang et al. · 2019 · Experimental Neurology
99. Novel 2, 5-diketopiperazine derivatives as potent selective histone deacetylase 6 inhibitors: Rational design, synthesis and antiproliferative activity
    Xin Chen, Xinyang Chen, Raphael R. Steimbach, Tong Wu, Hongmei Li, Wenjia Dan, Peidong Shi, Chenyu Cao, Ding Li, Aubry K. Miller et al. · 2019 · European Journal of Medicinal Chemistry
100. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors
     Wendy Anne Gold, T. A. Lacina, Laurence C. Cantrill, John Christodoulou · 2014 · Journal of Molecular Medicine